MBOT

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change +0.02
Percentage change 2.00	%

Peers: ISRG TMO MDT SYK BDX EW ZBH ABT GMED WAT

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.80	Insider Own	2.30%	Shs Outstand	16.65M	Perf Week	3.03%
Market Cap	17.27M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	16.55M	Perf Month	0.99%
Income	-11.21M	PEG	-	EPS next Q	-	Inst Own	6.76%	Short Float	3.51%	Perf Quarter	6.28%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-3.36%	Short Ratio	3.39	Perf Half Y	-6.42%
Book/sh	0.23	P/B	4.46	EPS next Y	-	ROA	-158.98%	Short Interest	0.58M	Perf Year	-15.70%
Cash/sh	0.26	P/C	3.93	EPS next 5Y	-	ROE	-200.70%	52W Range	0.82 - 2.35	Perf YTD	-37.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	15.28%	ROI	-292.03%	52W High	-56.59%	Beta	1.51
Dividend TTM	-	Quick Ratio	3.64	Sales past 5Y	0.00%	Gross Margin	-	52W Low	24.39%	ATR (14)	0.05
Dividend Ex-Date	-	Current Ratio	3.64	EPS Y/Y TTM	33.20%	Oper. Margin	-	RSI (14)	58.46	Volatility	4.84% 5.88%
Employees	22	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	7.00
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	6.56%	Payout	-	Rel Volume	1.87	Prev Close	1.00
Sales Surprise	-	EPS Surprise	0.00%	Sales Q/Q	-	Earnings	Aug 13	Avg Volume	171.57K	Price	1.02
SMA20	5.07%	SMA50	5.36%	SMA200	0.41%	Trades		Volume	321,581	Change	2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-13-20	Reiterated	H.C. Wainwright	Buy	$12 → $26
Dec-24-19	Reiterated	H.C. Wainwright	Buy	$10 → $12
Jan-31-18	Initiated	Ladenburg Thalmann	Buy	$1.75

Today 05:00AM	Microbot Medical seeks FDA clearance for endovascular robotic system (Medical Device Network)
Dec-10-24 10:18AM	Microbot Medical CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access (GlobeNewswire)
08:00AM	Microbot Medical Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System (GlobeNewswire)
Dec-03-24 08:45AM	Global Medical Service Robotics Market Project to Exceed $20 Billion in 2024 with Additional Growth Expected (GlobeNewswire)
Oct-15-24 11:21AM	Microbot eyes FDA application for surgical robot after completing pivotal trial (Medical Device Network)
08:38AM	Loading…
08:38AM	Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY during 2Q 2025 (GlobeNewswire)
Sep-30-24 08:30AM	Microbot Medical Accelerates Patient Enrollment of its Pivotal Human Clinical Trial; Expects to Complete the Trial Earlier Than Anticipated as 80% of Patients Have Completed Follow up (GlobeNewswire)
Sep-17-24 08:30AM	Microbot Medical Announces the Successful Enrollment of 50% of the Patients in its Pivotal Human Clinical Trial for the LIBERTY Endovascular Robotic Surgical System (GlobeNewswire)
Aug-29-24 05:32AM	Microbot Medical advances Liberty Robotic System telesurgery innovation (Medical Device Network)
Aug-23-24 11:59AM	Microbot Medical (MBOT) Inks New Phase 2 Agreement for LIBERTY (Zacks)
Aug-22-24 08:30AM	Microbot Medical Signs Phase 2 Collaboration Agreement with Corewell Health to Advance Remote Telesurgery Using the LIBERTY Endovascular Robotic System (GlobeNewswire) -6.25%
Aug-19-24 11:01AM	Microbot Medical (MBOT) Gets Quality Certification for its System (Zacks)
Aug-13-24 08:30AM	Microbot Medical Receives Quality Certification to Support Future Regulatory Submissions and Commercialization (GlobeNewswire)
Aug-05-24 11:29AM	Microbot Medical (MBOT) Inks Deal to Test Autonomous Robotics (Zacks)
Aug-02-24 06:52AM	Microbot and Emory University to advance endovascular robotic system (Medical Device Network) -5.19%
08:30AM	Loading…
Aug-01-24 08:30AM	Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY Endovascular Robotic Surgical System (GlobeNewswire)
Jul-18-24 08:30AM	Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center (GlobeNewswire)
Jul-11-24 01:47PM	Microbot Medical (MBOT) Progresses in Its Human Clinical Trial (Zacks)
Jul-09-24 08:30AM	Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial (GlobeNewswire)
Jul-08-24 08:20AM	Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial (GlobeNewswire)
Jul-05-24 11:48AM	Microbot Medical (MBOT) Inks Agreement to Begin LIBERTY Trial (Zacks)
08:13AM	Microbot secures second site for Liberty endovascular robot trial (Medical Device Network)
Jul-04-24 01:49PM	Microbot (MBOT) Inks a New Agreement to Begin Trial on LIBERTY (Zacks)
Jul-03-24 08:20AM	Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial (GlobeNewswire) +6.06%
Jun-26-24 11:14AM	Transforming surgery: Microbot Medical and Boston hospital collaborate on Liberty Surgical Robot trials (Medical Device Network)
Jun-21-24 06:53AM	Microbot partners with Boston Hospital to trial Liberty surgical robot (Medical Device Network)
Jun-20-24 08:25AM	Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial (GlobeNewswire)
Jun-17-24 08:30AM	Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial (GlobeNewswire)
Jun-04-24 04:20PM	Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -17.39%
06:26AM	Microbots LIBERTY robotic system secures FDA approval for pivotal trial (Medical Device Network)
12:11PM	Loading…
Jun-03-24 12:11PM	Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) +38.00%
08:20AM	Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial (GlobeNewswire)
May-15-24 11:53PM	MBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024 (InvestorPlace)
Apr-29-24 08:30AM	Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health (GlobeNewswire) +7.84%
Apr-15-24 08:30AM	Microbot Medical Shares Status Following Recent Geopolitical Events (GlobeNewswire)
Mar-27-24 10:53PM	MBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023 (InvestorPlace) +6.96%
Feb-07-24 10:08AM	Microbot Medical (MBOT) Files IDE to Start Human Clinical Study (Zacks)
Feb-05-24 07:30AM	Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US (GlobeNewswire)
Jan-30-24 07:20AM	Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters (GlobeNewswire) -5.38%
Jan-18-24 07:20AM	Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study (GlobeNewswire) +6.35%
Jan-03-24 10:12AM	Microbot Medical (MBOT) Announces Positive GLP Study Results (Zacks)
Dec-29-23 08:00AM	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -20.00%
Dec-28-23 07:30AM	Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met (GlobeNewswire) +55.30%
Dec-14-23 08:15AM	Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY Endovascular Robotic Surgical System for Telerobotic (GlobeNewswire)
Dec-10-23 02:31PM	3 Stocks at the Forefront of Medical Robotics (InvestorPlace)
Dec-07-23 08:00AM	Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study (GlobeNewswire)
Nov-21-23 09:12AM	Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities (GlobeNewswire)
Nov-13-23 08:30AM	Microbot Medical Successfully Completed Integral Part of the Verification and Validation Process (GlobeNewswire)
Nov-08-23 09:10AM	Microbot Medical Granted Registered Trademark from The U.S. Patent and Trademark Office (GlobeNewswire) +8.70%
Oct-31-23 08:25AM	Microbot Medical Reveals Successful Short Term Follow Up Outcomes from its Pivotal Pre-Clinical Study (GlobeNewswire) +6.19%
Oct-24-23 08:19AM	Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024 (GlobeNewswire)
Oct-19-23 08:20AM	Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company (GlobeNewswire) -7.53%
Oct-17-23 09:28AM	Microbot Medical Announces Successful Initial Outcomes from Its Pivotal Pre-Clinical Study with the LIBERTY Robotic Surgical System (GlobeNewswire) +14.96%
Sep-27-23 08:30AM	Microbot Medical Engages CRO to Support its Upcoming U.S. Pivotal Clinical Trial (GlobeNewswire)
Sep-08-23 10:02AM	Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY® Robotic Surgical System at CIRSE 2023 (GlobeNewswire)
Aug-15-23 08:30AM	Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System (GlobeNewswire)
Aug-10-23 08:30AM	Microbot Medical Strengthens Its Position Among US Interventional Radiologists by Appointing Professor Francois H. Cornelis to Its Scientific Advisory Board (GlobeNewswire)
Jul-25-23 09:23AM	Microbot Medical Engaging with a Leading Notified Body to Advance CE Mark for Sales in Europe (GlobeNewswire)
Jul-11-23 08:30AM	Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board (GlobeNewswire)
Jun-29-23 08:30AM	Microbot Medical Successfully Completes an Extensive Pre-Clinical Study Performed in the US (GlobeNewswire)
Jun-28-23 02:05PM	Microbot Medical Raises a Total of $7.6 Million in Gross Proceeds from Four Recent Registered Direct Offerings (GlobeNewswire)
Jun-27-23 08:00AM	Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -16.81%
Jun-22-23 08:36AM	Microbot Medical Expand IP protection in Japan (GlobeNewswire)
Jun-16-23 08:30AM	Microbot Medical Announces Multiple Peer Reviewed Abstracts Accepted by The Cardiovascular and Interventional Radiological Society of Europe (GlobeNewswire) +7.34%
Jun-06-23 12:33PM	Microbot Medical Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) +10.40%
Jun-02-23 12:36PM	Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -18.52%
08:15AM	Microbot Medical Receives a Non-Dilutive Grant from The Israel Innovation Authority Supporting the Development of the Manufacturing Process for its Endovascular Surgical Robotic System (GlobeNewswire)
May-31-23 08:30AM	LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process (GlobeNewswire)
May-25-23 08:40AM	Lahey Hospital & Medical Center Agrees to become One of the U.S. Sites for the LIBERTY® Robotic Systems First Human Trial (GlobeNewswire) +10.99%
May-24-23 01:05PM	Microbot Medical Announces Closing of $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -12.79%
May-23-23 03:24PM	Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules (GlobeNewswire) -31.35%
02:25PM	3 Undervalued Penny Stocks to Buy for Multi-Bagger Returns (InvestorPlace)
01:41PM	Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules (GlobeNewswire)
May-22-23 03:18PM	Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules (GlobeNewswire) +159.35%
02:52PM	Microbot Medical Stock Shoots Higher: Here's Why (Benzinga)
08:30AM	Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians (GlobeNewswire)
May-18-23 09:15AM	Microbot Medical to Enhance Focus on its Core Business and Prioritize Preparations for Regulatory and First in Human Clinical Cases (GlobeNewswire)
May-08-23 08:30AM	Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System (GlobeNewswire)
May-05-23 09:00AM	Microbot Medical Announces Final Data From Its Recent Animal Study (GlobeNewswire)
May-03-23 09:00AM	Microbot Medicals LIBERTY® Robotic System Surpasses 100th Catheterization (GlobeNewswire) -17.42%
Mar-23-23 09:00AM	Gerry OSullivan, the Latest Member to Join Microbot Medicals Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY® Robotic System Through Regulatory, Clinical and Commercialization Phases (GlobeNewswire) +5.88%
Mar-16-23 09:00AM	Microbot Medical Launches Presence in the United Kingdom as Highly Accomplished Consultant Interventional Radiologist Professor Mark W. Little Joins its Scientific Advisory Board as Efforts to Commercialize the LIBERTY® Robotic System Continue to Accelerate (GlobeNewswire) +15.67%
Mar-13-23 09:00AM	Microbot Medical Increases Presence in the EU with the Addition of Greece-based Key Opinion Leader Stavros Spiliopoulos, MD, PhD, EBIR-ES, FCIRSE, to its Scientific Advisory Board (GlobeNewswire)
Mar-09-23 09:00AM	Microbot Medicals Chief Medical Officer Dr. Eyal Morag to Highlight Performance, Safety and Usability Benefits of the LIBERTY® Robotic System During Podium Presentation at Prestigious Robotics Conference (GlobeNewswire) -7.03%
Mar-02-23 09:00AM	Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System (GlobeNewswire) +7.14%
Feb-28-23 09:00AM	Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting (GlobeNewswire)
Feb-27-23 09:00AM	Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board (GlobeNewswire) +12.64%
Feb-23-23 08:00AM	Microbot Medicals Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan (GlobeNewswire)
Jan-31-23 07:30AM	Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next Access-Ability Live by MBOT Webinar Series (GlobeNewswire)
Jan-06-23 07:00AM	Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next Access-Ability Live by MBOT Webinar (GlobeNewswire)
Dec-21-22 09:55AM	Microbot Medical Inc. (MBOT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Dec-14-22 08:30AM	Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next Access-Ability Live by MBOT Webinar Series (GlobeNewswire)
Dec-08-22 07:00AM	Microbot Medicals Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel (GlobeNewswire)
Nov-21-22 03:04PM	10 Best Robotic Stocks Under $10 (Insider Monkey)
Nov-18-22 09:00AM	Microbot Medicals Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance (GlobeNewswire)
Nov-15-22 07:00AM	Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space (GlobeNewswire) +11.85%
Nov-08-22 06:42AM	Here's Why Microbot Medical (NASDAQ:MBOT) Must Use Its Cash Wisely (Simply Wall St.)
Nov-03-22 07:00AM	Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System (GlobeNewswire)
Oct-31-22 07:00AM	Microbot Medical Adds the Head of the Interventional Radiology Unit of Europes Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board (GlobeNewswire)
Oct-25-22 04:01PM	Microbot Medical Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules (GlobeNewswire)

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Braintree, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Microbot Medical Inc

Upgrade your FINVIZ experience